Quatramer™ encapsulation of dual‐targeted PI3‐Kδ/HDAC6 inhibitor, HSB‐510, suppresses growth of breast cancer

Quatramer™ encapsulation of dual‐targeted PI3‐Kδ/HDAC6 inhibitor, HSB‐510, suppresses growth of breast cancer

Abstract Multiple studies have shown that the progression of breast cancer depends on multiple signaling pathways, suggesting that therapies with multitargeted anticancer agents will offer improved therapeutic benefits through synergistic effects in inhibiting cancer growth. Dual‐targeted inhibitors...

Full description

Bibliographic Details
Main Authors: Sachchidanand Tiwari, Suiyang Liu, Mohd Anees, Neha Mehrotra, Ashish Thakur, Gregory J. Tawa, Gurmit Grewal, Richard Stone, Surender Kharbanda, Harpal Singh
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Bioengineering & Translational Medicine
Subjects:
breast cancer
HDAC6
Nanoformulation
PI3‐Kδ
PLA
Online Access:https://doi.org/10.1002/btm2.10541

Internet

https://doi.org/10.1002/btm2.10541

Similar Items